Literature DB >> 7399714

Significance of pleural and sputum concentrations for antibiotic therapy of bronchopulmonary infections.

H Lode, G Gruhlke, W Hallermann, G Dzwillo.   

Abstract

Tests were done with various antibiotics (ampicillin, carbenicillin, cefazolin, cefotaxime, cephradine, ticarcillin) in order to determine the significance of sputum and pleural concentrations for adequate therapy of bronchopulmonary infections. In a total of 19 chronic bronchitis patients, it was found that the attainable sputum concentrations were rather low and that individual fluctuations were great. No clear connection was evident between dosage and concentration of antibiotics in the sputum. In 17 patients with exudative pleurisy, test data yielded in pleural kinetics largely corresponded with data from animal experiment models. The pleural cavity can be described as a partial extracellular, extravascular compartment in which the concentration course probably correlates more to the interstitial lung concentrations than to that of the sputum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399714     DOI: 10.1007/bf01644936

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

Review 1.  Cefpodoxime proxetil in upper respiratory tract infections.

Authors:  E Bergogne-Berezin
Journal:  Drugs       Date:  1991       Impact factor: 9.546

2.  Penetration of antibiotics into the respiratory tract.

Authors:  J Symonds
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

3.  Penetration and clearance of cefoperazone and moxalactam in pleural fluid.

Authors:  H Yamada; T Iwanaga; H Nakanishi; M Yamaguchi; K Iida
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

Review 4.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.